File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Cardiovascular disease in end-stage renal disease

TitleCardiovascular disease in end-stage renal disease
Authors
Issue Date2006
Citation
Hong Kong Journal of Nephrology, 2006, v. 8, n. 1, p. 10-16 How to Cite?
AbstractCardiovascular disease is the leading cause of morbidity and mortality in patients with end-stage renal disease. It accounts for nearly half of the mortality in end-stage renal disease patients on maintenance dialysis treatment. The spectrum of cardiovascular disease is diverse, including vascular disease and myocardial disease, and the two commonly coexist and are interrelated with each other. Apart from considering the traditional Framingham risk factors, there is increasing recognition of the importance of non-traditional risk factors in predisposing patients with end-stage renal disease to this high incidence of cardiovascular complications, including excessive calcium phosphorus load, hyperparathyroidism, anemia, hemodynamic overload, inflammation, increased asymmetric dimethylarginine and oxidative stress. Cardiovascular disease in end-stage renal disease patients commonly manifests as ischemic heart disease or acute coronary syndrome, stroke, peripheral vascular disease and congestive heart failure. According to the United States Renal Data System, the annual incidence of new-onset ischemic heart disease, stroke, peripheral vascular disease and congestive heart failure was estimated to be approximately 5%, 1%, 7% and 7%, respectively. In order to improve the cardiovascular outcomes of endstage renal disease patients receiving maintenance dialysis therapy, a better understanding of the nature and severity of cardiovascular disease as well as risk factors associated with the different cardiovascular complications is required.
Persistent Identifierhttp://hdl.handle.net/10722/228414
ISSN
2015 SCImago Journal Rankings: 0.166

 

DC FieldValueLanguage
dc.contributor.authorWang, A. Y M-
dc.contributor.authorTak-Mao, Daniel-
dc.contributor.authorLai, Kar Neng-
dc.date.accessioned2016-08-13T08:02:21Z-
dc.date.available2016-08-13T08:02:21Z-
dc.date.issued2006-
dc.identifier.citationHong Kong Journal of Nephrology, 2006, v. 8, n. 1, p. 10-16-
dc.identifier.issn1561-5413-
dc.identifier.urihttp://hdl.handle.net/10722/228414-
dc.description.abstractCardiovascular disease is the leading cause of morbidity and mortality in patients with end-stage renal disease. It accounts for nearly half of the mortality in end-stage renal disease patients on maintenance dialysis treatment. The spectrum of cardiovascular disease is diverse, including vascular disease and myocardial disease, and the two commonly coexist and are interrelated with each other. Apart from considering the traditional Framingham risk factors, there is increasing recognition of the importance of non-traditional risk factors in predisposing patients with end-stage renal disease to this high incidence of cardiovascular complications, including excessive calcium phosphorus load, hyperparathyroidism, anemia, hemodynamic overload, inflammation, increased asymmetric dimethylarginine and oxidative stress. Cardiovascular disease in end-stage renal disease patients commonly manifests as ischemic heart disease or acute coronary syndrome, stroke, peripheral vascular disease and congestive heart failure. According to the United States Renal Data System, the annual incidence of new-onset ischemic heart disease, stroke, peripheral vascular disease and congestive heart failure was estimated to be approximately 5%, 1%, 7% and 7%, respectively. In order to improve the cardiovascular outcomes of endstage renal disease patients receiving maintenance dialysis therapy, a better understanding of the nature and severity of cardiovascular disease as well as risk factors associated with the different cardiovascular complications is required.-
dc.languageeng-
dc.relation.ispartofHong Kong Journal of Nephrology-
dc.titleCardiovascular disease in end-stage renal disease-
dc.typeArticle-
dc.description.natureLink_to_subscribed_fulltext-
dc.identifier.scopuseid_2-s2.0-33646261887-
dc.identifier.volume8-
dc.identifier.issue1-
dc.identifier.spage10-
dc.identifier.epage16-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats